Tenascin - A marker for the malignant potential of preinvasive breast cancers

Gynecologic Oncology

Volumn 79, Issue 3, 2000, Pages 372-378

  Goepel, Christian ^a   Buchmann, Joerg ^a   Schultka, Ruediger ^a   Koelbl, Heinz ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Breast cancer; Ductal carcinoma in situ (DCIS); Immunofluorescence; Malignancy; Premalignant; Tenascin

Indexed keywords

GLYCOPROTEIN; SCLEROPROTEIN; TENASCIN;

ADULT; ARTICLE; BREAST BIOPSY; BREAST CANCER; CANCER INVASION; FEMALE; HUMAN; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION;

EID: 0033670099     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.2000.5978     Document Type: Article

References (36)

1. Tenascin: An extracellular matrix protein prominent in specialized embryonic tissues and tumors
2. Tenascin-C, tenascin-R and tenascin-X: A family of talented proteins in search of functions
3. Tenascin during gut development: Appearance in the mesenchyme, shift in molecular forms, and dependence on epithelial-mesenchymal interactions
4. Comparison of human tenascin expression in normal, simian-virus-40-transformed and tumor-derived cell lines
5. Tenascin: An extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis
6. The complexity in regulating the expression of tenascin
7. Tenascin in normal, reactive, hyperplastic and neoplastic tissue. Biologic and pathologic implications
8. Age-dependent changes of the immunohistochemical distribution of various collagen types and structural glycoproteins in the human uterine tube
9. Age-dependent collagen and glycoprotein distribution in the blood vessels of the human tuba uterina
10. Epithelial induction of stromal tenascin in the mouse mammary gland: From embryogenesis to carcinogenesis
11. Tenascin mediates cell attachment through an RGD-dependent receptor
12. Expression of adhesion factors and degrading proteins in primary and secondary glioblastomas and their precursor tumors
13. Tenascin is a stromal marker for epithelial malignancy in the mammary gland
14. Tenascin distribution in the normal human breast is altered during the menstrual cycle and in carcinoma
15. Tenascin/hexabrachion in human skin: Biochemical identification and localization by light and electron microscopy
16. Extracellular matrix proteins and VLA integrins expression in the microenvironment of human lung carcinoma
17. Expression of tenascin in hamster buccal pouch mucosa during experimental carcinogenesis
18. Relationship of transforming growth factor beta 1 to extracellular matrix and stromal infiltrates in invasive breast carcinoma
19. Differential distribution of tenascin in the normal, hyperplastic and neoplastic breast
20. Comparative analysis of the expression of tenascin and established prognostic factors in human breast cancer
21. Prognostic classification of breast ductal carcinoma-in-situ
22. Biochemical and structural studies of tenascin/hexabrachion proteins
23. A cDNA clone for cytotactin contains sequences similiar to epidermal growth factor-like repeats and segments of fibronectin and fibrinogen
24. Enhanced tenascin expression in cervical and koilocytotic lesions
25. Can tenascin be redundant in cancer development?
26. Tenascin staining positivity and the survival of patients with invasive breast carcinomas
27. Tenascin positivity and the survival of patients with invasive breast carcinomas
28. Expression of tenascin in invasion border of early breast cancer correlates with higher risk of distant metastasis
29. Expression of tenascin-C in intraductal carcinoma of human breast: Relationship to invasion
30. Tenascin-C expression in invasion border of early breast cancer - A predictor of local and distant recurrence
31. Immunhistochemical localisation of tenascin in invasive ductal carcinoma of breast
32. p53, ErbB2, and TAG-72 expression in the spectrum of ductal carcinoma in situ of the breast classified by the Van Nuys system
33. Molecular immunohistochemical analysis of p53 mutations in scrapings and tissue from preinvasive and invasive breast cancer
34. Biological profile of in situ breast cancer investigated by immunhistochemical technique
35. Stimulation of tenascin expression in mesenchyme by epithelial-mesenchymal interactions
36. Tenascin variants: Differential binding to fibronectin and distinct distribution in cell cultures and tissues